Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein
- PMID: 11356936
Delivery across the blood-brain barrier of antisense directed against amyloid beta: reversal of learning and memory deficits in mice overexpressing amyloid precursor protein
Abstract
Amyloid beta protein (Abeta) may play a causal role in Alzheimer's disease. Previous work has shown that the learning and memory deficits that develop with aging in SAMP8 mice, a strain that overproduces Abeta, can be reversed with i.c.v. injections of an Abeta antisense phosphorothiolate oligonucleotide (Olg). Here, we showed that Olg radioactively labeled with (32)P (P-Olg) was transported intact across the blood-brain barrier (BBB) of mice by a saturable system, termed oligonucleotide transport system-1 (OTS-1). Multiple-time regression analysis found a blood-to-brain unidirectional influx rate for P-Olg of 1.4 +/- 0.39 microl/g-min and capillary depletion showed that P-Olg completely crossed the BBB to enter the parenchymal space of the brain. P-Olg was also shown to enter the cerebrospinal fluid. Transport was especially high into the hippocampus, with the percentage of the i.v. dose taken up by each gram of brain (0.865 +/- 0.115%) being about 1/100 of the i.c.v. dose. An i.v. dose of Olg 100 times that of the effective i.c.v. dose reversed the learning and memory deficits of aged SAMP8 mice. These studies show for the first time that phosphorothiolate oligonucleotides can be delivered to the brain in effective doses by intravenous administration.
Similar articles
-
Impairments in brain-to-blood transport of amyloid-β and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-β protein precursor.J Alzheimers Dis. 2011;23(4):599-605. doi: 10.3233/JAD-2010-100021. J Alzheimers Dis. 2011. PMID: 21098986
-
Peripheral administration of antisense oligonucleotides targeting the amyloid-β protein precursor reverses AβPP and LRP-1 overexpression in the aged SAMP8 mouse brain.J Alzheimers Dis. 2012;28(4):951-60. doi: 10.3233/JAD-2011-111517. J Alzheimers Dis. 2012. PMID: 22179572
-
Permeability of proteins at the blood-brain barrier in the normal adult mouse and double transgenic mouse model of Alzheimer's disease.Neurobiol Dis. 2001 Aug;8(4):555-67. doi: 10.1006/nbdi.2001.0402. Neurobiol Dis. 2001. PMID: 11493021
-
Why Alzheimer's disease starts with a memory impairment: neurophysiological insight.J Alzheimers Dis. 2010;20(1):5-16. doi: 10.3233/JAD-2009-1339. J Alzheimers Dis. 2010. PMID: 20378956 Review.
-
The SAMP8 mouse: a model to develop therapeutic interventions for Alzheimer's disease.Curr Pharm Des. 2012;18(8):1123-30. doi: 10.2174/138161212799315795. Curr Pharm Des. 2012. PMID: 22288401 Review.
Cited by
-
Cholesterol-functionalized DNA/RNA heteroduplexes cross the blood-brain barrier and knock down genes in the rodent CNS.Nat Biotechnol. 2021 Dec;39(12):1529-1536. doi: 10.1038/s41587-021-00972-x. Epub 2021 Aug 12. Nat Biotechnol. 2021. PMID: 34385691
-
Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce α-synuclein in a mouse model of Alzheimer's disease.Neurobiol Dis. 2023 Oct 1;186:106285. doi: 10.1016/j.nbd.2023.106285. Epub 2023 Sep 9. Neurobiol Dis. 2023. PMID: 37690676 Free PMC article.
-
Animal models in the drug discovery pipeline for Alzheimer's disease.Br J Pharmacol. 2011 Oct;164(4):1285-300. doi: 10.1111/j.1476-5381.2011.01299.x. Br J Pharmacol. 2011. PMID: 21371009 Free PMC article. Review.
-
MicroRNAs as Molecular Targets for Cancer Therapy: On the Modulation of MicroRNA Expression.Pharmaceuticals (Basel). 2013 Sep 30;6(10):1195-220. doi: 10.3390/ph6101195. Pharmaceuticals (Basel). 2013. PMID: 24275848 Free PMC article.
-
Drug delivery to the brain in Alzheimer's disease: consideration of the blood-brain barrier.Adv Drug Deliv Rev. 2012 May 15;64(7):629-39. doi: 10.1016/j.addr.2011.12.005. Epub 2011 Dec 17. Adv Drug Deliv Rev. 2012. PMID: 22202501 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases